4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0000950170-24-063531
President & CEO sold 25,037 shares at $2.86 ($71,576)
- President & CEO acquired 25,037 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GOOD JENNIFER L · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-20 | Exercise or conversion : show line 1 in the form | +25,037 | $2.19 | $54,831 | 238,350 | D |
| 2024-05-20 | Sale : show line 2 in the form | −25,037 | $2.86 | $71,576 | 213,313 | D |
| Open-market sales · 25,037 sh · avg $2.86 · $71,576 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-20 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −25,037 | 33,189 | D |
Loading xslF345X05/ownership.xml…